Health

Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights

January 13, 2026 07:05 ET  | Source: Sight Sciences, Inc. MENLO PARK, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Sight…

1 month ago

Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue

January 13, 2026 07:05 ET  | Source: Treace Medical Concepts, Inc. PONTE VEDRA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) --…

1 month ago

Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA (nusinersen) for Spinal Muscular Atrophy

Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28…

1 month ago

BridgeBio Announces Commercial Progress, Program Updates, and 2026 Milestones at the 44th Annual J.P. Morgan Healthcare Conference

January 12, 2026 10:30 ET  | Source: BridgeBio Pharma, Inc. - Preliminary unaudited Q4 and Full Year 2025 net Attruby® product…

1 month ago

SafeSpace Global Corporation (OTCID: SSGC) Issues CEO Letter to Shareholders

Knoxville, TN, Jan. 12, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID: SSGC), a leading AI technology company delivering multimodal…

1 month ago

Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference

January 11, 2026 13:00 ET  | Source: Krystal Biotech, Inc. Preliminary 4Q 2025 VYJUVEK net revenue of $106 million to…

1 month ago

RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer

January 11, 2026 09:30 ET  | Source: RxSight, Inc. ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST)…

1 month ago

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at month-24 post-treatment Patient 1 continued…

1 month ago

Best GLP-1 Patch with Berberine (2026): Search Term Analysis as Consumers Explore Natural Transdermal Alternatives Vitamin Patch Club’s TrimPure Gold Referenced in Category Report

CENTERVILLE, Utah, Jan. 10, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and doesn't constitute medical…

1 month ago

Calm Nature CBD Gummies Ingredients: 2026 Consumer Analysis Examines Full Spectrum CBD Claims, Testing Standards, and Formulation Transparency

DENVER, CO, Jan. 10, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not constitute…

1 month ago